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Autism is estimated to occur in 1 of 88 
children [Centers for Disease Control and 
Prevention (CDC) 2012]. Although the etiol-
ogy of autism is still unknown, both genetic 
factors and environmental exposures have 
been implicated (Newschaffer et al. 2007). 
Exposure to exogenous agents may especially 
affect autism risk when it occurs during fetal 
development (Rodier et al. 1996).
In utero tobacco exposure via direct smok-
ing by the mother has been associated with 
neurodevelopmental deficits such as cogni-
tive impairments and behavioral problems, 
suggesting that such exposure is neurotoxic 
(Braun et al. 2009; DiFranza et al. 2004; 
Mendola et al. 2002). Potential mechanisms 
that may underlie this relationship include 
fetal hypoxia and modulation of neurotrans-
mitter systems via nicotinic acetylcholine 
receptors (Burstyn et al. 2011; Slotkin 2004; 
Soothill et al. 1996). Yet primary tobacco 
exposure in pregnancy remains an important 
and preventable public health concern: 13% 
of infants in the United States were exposed 
to maternal smoking during pregnancy in 
1999–2006 (Dietz et al. 2011).
The literature on tobacco exposure during 
pregnancy and subsequent autism spectrum 
disorders (ASDs) is inconclusive. Studies in 
the United States, Europe, and China have 
reported associations that are inverse (Juul-
Dam et al. 2001; Williams et al. 2003), close to 
null (Burstyn et al. 2010; Larsson et al. 2005; 
Lee et al. 2011; Maimburg and Vaeth 2006) 
and elevated (Hultman et al. 2002; Indredavik 
et al. 2007; Larsson et al. 2009; Zhang et al. 
2010). These studies varied widely in design, 
case definition, and ability to control for social 
class influences. Furthermore, the practices of 
autism screening, access to diagnostic health 
services, and social norms around tobacco use 
varied greatly among the studied countries. 
Such factors may have influenced study results.
To clarify the association between mater-
nal smoking in pregnancy and the subsequent 
development of an ASD, we conducted a 
study using a large number of cases from a 
population-based U.S. surveillance program, 
the Autism and Developmental Disabilities 
Monitoring (ADDM) network. We controlled 
for social and demographic confounding fac-
tors, evaluated case subgroups, and explored 
data limitations using sensitivity analyses.
Methods
Study population. We implemented a 
 population-based, case–cohort design, using 
ASD surveillance data from ADDM and pub-
licly available birth certificate files from the 
National Center for Health Statistics (NCHS) 
(CDC 2009a) and the North Carolina State 
Center for Health Statistics (Howard W. 
Odum Institute for Research in Social Science 
at the University of North Carolina at Chapel 
Hill 2009). Our study population was defined 
as all children born in 1992, 1994, 1996, 
and 1998 who resided at birth within regions 
subsequently under ADDM surveillance dur-
ing their 8th year of life. We excluded some 
counties with populations < 100,000 in which 
Address correspondence to A. Kalkbrenner, Zilber 
School of Public Health, University of Wisconsin–
Milwaukee, Alumni House, 3230 E. Kenwood Blvd., 
Milwaukee, WI 53201-0413 USA. Telephone: (414) 
229-7136. Fax: (414) 229-3943. E-mail: kalkbren@
uwm.edu
Supplemental Material is available online (http://
ox.doi.org/10.1289/ehp.1104556).
We gratefully acknowledge the many educational 
and medical service agencies who assisted in perform-
ing autism surveillance, J. Baio for his assistance in 
understanding nuances of autism surveillance data, and 
K. Cheslack-Postava for her suggestions for this study. 
This study was supported primarily by the Centers for 
Disease Control and Prevention (grants DD000089, 
DD000184, and U10DD000184, P30ES10126). 
The time contribution of some authors was supported 
by training grants from the National Institute of 
Environmental Health Sciences (grants T32 ES007018 
and T32 ES007069), and the Leaves of Grass Fund. 
The findings and conclusions in this report are 
those of the authors and do not necessarily repre-
sent the official position of the Centers for Disease 
Control and Prevention. 
The authors declare they have no actual or potential 
competing financial interests.
Received 29 September 2011; accepted 17 April 
2012.
Maternal Smoking during Pregnancy and the Prevalence of Autism Spectrum 
Disorders, Using Data from the Autism and Developmental Disabilities 
Monitoring Network
Amy E. Kalkbrenner,1 Joe M. Braun,2 Maureen S. Durkin,3 Matthew J. Maenner,4 Christopher Cunniff,5  
Li-Ching Lee,6 Sydney Pettygrove,7 Joyce S. Nicholas,8 and Julie L. Daniels9
1Zilber School of Public Health, University of Wisconsin–Milwaukee, Milwaukee, Wisconsin, USA; 2Department of Environmental Health, 
Harvard School of Public Health, Boston, Massachusetts, USA; 3Department of Population Health Sciences, University of Wisconsin 
School of Medicine and Public Health, Madison, Wisconsin, USA; 4Waisman Center, University of Wisconsin, Madison, Wisconsin, 
USA; 5Department of Pediatrics, University of Arizona College of Medicine, Tucson, Arizona, USA; 6Department of Epidemiology, 
Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; 7College of Public Health, University of Arizona, Tucson, 
Arizona, USA; 8Department of Medicine, Division of Biostatistics and Epidemiology, Medical University of South Carolina, Charleston, 
South Carolina, USA; 9Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Background: Reported associations between gestational tobacco exposure and autism spectrum 
disorders (ASDs) have been inconsistent.
oBjective: We estimated the association between maternal smoking during pregnancy and ASDs 
among children 8 years of age.
Methods: This population-based case–cohort study included 633,989 children, identified using 
publicly available birth certificate data, born in 1992, 1994, 1996, and 1998 from parts of 11 U.S. 
states subsequently under ASD surveillance. Of these children, 3,315 were identified as having 
an ASD by the active, records-based surveillance of the Autism and Developmental Disabilities 
Monitoring Network. We estimated prevalence ratios (PRs) of maternal smoking from birth cer-
tificate report and ASDs using logistic regression, adjusting for maternal education, race/ethnicity, 
marital status, and maternal age; separately examining higher- and lower-functioning case sub-
groups; and correcting for assumed under-ascertainment of autism by level of maternal education.
results: About 13% of the source population and 11% of children with an ASD had a report of 
maternal smoking in pregnancy: adjusted PR (95% confidence interval) of 0.90 (0.80, 1.01). The 
association for the case subgroup autistic disorder (1,310 cases) was similar: 0.88 (0.72, 1.08), 
whereas that for ASD not otherwise specified (ASD-NOS) (375 cases) was positive, albeit includ-
ing the null: 1.26 (0.91, 1.75). Unadjusted associations corrected for assumed under-ascertainment 
were 1.06 (0.98, 1.14) for all ASDs, 1.12 (0.97, 1.30) for autistic disorder, and 1.63 (1.30, 2.04) for 
ASD-NOS.
conclusions: After accounting for the potential of under-ascertainment bias, we found a null 
 association between maternal smoking in pregnancy and ASDs, generally. The possibility of an 
 association with a higher-functioning ASD subgroup was suggested, and warrants further study.
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birth county is suppressed in birth certifi-
cate files and excluded some ADDM regions 
in which surveillance was incomplete within 
county boundaries. Finally, we restricted the 
sample to ADDM sites that were able to suc-
cessfully obtain the needed birth certificate 
variables. Regions included for at least 1 year 
in this study included 5 northern counties in 
Alabama, all of Arkansas, Miami-Dade county 
in Florida, 5 counties in metropolitan Atlanta 
in Georgia, Baltimore county and 5 surround-
ing counties in Maryland, 6 counties in met-
ropolitan St. Louis in Missouri and Illinois, 
Union County just south of Newark in New 
Jersey, 10 counties surrounding Greensboro 
and Durham in North Carolina, Philadelphia 
County in Pennsylvania, 5 counties in south-
eastern Wisconsin including Milwaukee, and 
all of West Virginia.
Surveillance ascertainment and case sub-
groups. Cases were all children with ADDM 
surveillance-ascertained ASDs born within 
the source population as defined above. 
The ADDM network has performed active, 
 population-based surveillance for ASDs in 
select regions of the United States biannually 
since 2000. The surveillance methodology does 
not directly evaluate children, but relies on 
developmental records through the child’s 8th 
year of life at key agencies, including medical 
agencies, early intervention services, and pub-
lic schools (CDC 2007, 2009b; Van Naarden 
Braun et al. 2007). An ADDM clinician ascer-
tained whether characteristics and behaviors in 
a child’s developmental record met the stan-
dardized ADDM case definition for ASDs, 
based on the Diagnostic and Statistical Manual, 
Fourth Edition–Text Revision (DSM-IV-TR) 
(American Psychiatric Association 2000). 
Information on these children was obtained 
in compliance with all applicable regulations 
for the protection of human health and educa-
tional data, including approval by institutional 
review boards in each ADDM region.
The ADDM network recorded variables 
that further characterized the phenotype for 
children meeting the ADDM case definition 
of ASD. Variables that were abstracted directly 
from the developmental record included 
a) community diagnosis: whether a commu-
nity provider had ever diagnosed the child 
with autistic disorder (AD) and/or ASD not 
otherwise specified (ASD-NOS); and, if so, 
b) timing of diagnosis: whether the child’s age 
in months at the earliest documented diagno-
sis was early (dichotomized using the median 
value, < 50 months) or late (≥ 50 months), 
and c) co-occurring intellectual disability 
(ID), defined as IQ ≤ 70 on tests such as the 
Battelle–cognitive domain (Newborg 2004), 
Differential Ability Scales (Elliott 2007), 
Stanford-Binet–4th ed. (Thorndike et al. 1986), 
Wechsler Intelligence Scale for Children-III 
(Wechsler 1991), and the Wechsler Preschool 
and Primary Scale of Intelligence (Wechsler 
1989). A fourth case subgrouping variable was 
newly derived by ADDM clinicians based on a 
review of the entire composite record; clinicians 
classified cases as AD, requiring documented 
symptoms corresponding to DSM-IV-TR cri-
teria for AD, or ASD-NOS, requiring fewer or 
less severe symptoms and including Asperger’s 
disorder and pervasive developmental disorder.
Children could be identified as cases only 
if they resided within the surveillance regions 
when they were 8 years of age. We limited the 
case group to those children also born within the 
surveillance areas so that our case group arose 
from the underlying population. We deter-
mined county of birth from birth certificate data 
obtained by each ADDM surveillance site.
Maternal smoking in pregnancy and 
covariates. Information on maternal smoking 
during pregnancy was obtained from birth 
certificate data. Smoking is collected using a 
yes/no check-box in a method that varies by 
state but usually involves abstraction of the 
medical record. Demographic factors, includ-
ing maternal education, age, marital status, 
and race/ethnicity were also obtained from 
birth certificates. We used a variable of county 
population size available in the NCHS birth 
certificate data as a proxy for the urbanicity of 
each county (Table 1).
Primary statistical analysis. We estimated 
prevalence ratios (PRs) of ASD by level of 
maternal smoking (yes/no) using logistic regres-
sion. We did not identify or remove cases from 
the denominator data; consequently, cases were 
included in the denominator data set represent-
ing all children born in the eligible geographic 
regions and birth years. Thus, odds ratios from 
these models are mathematically equivalent 
to PRs. We were unable to confirm the ASD 
status for individuals who moved out of the 
surveillance region between birth and 8 years 
of age, leading to a slight underestimation of 
prevalence. We included factors in multivari-
able models that may have the potential to 
confound the association between maternal 
smoking, and excluded factors that may be 
acting as causal intermediaries because they are 
influenced by maternal smoking (e.g., low birth 
weight) (Cole and Hernan 2002; Greenland 
and Brumback 2002). Selected potential con-
founders included maternal education (mod-
eled using restricted quadratic splines) (Durkin 
et al. 2010), race and ethnicity (categorized 
as non-Hispanic white, non-Hispanic black, 
Hispanic, or other) (Mandell et al. 2009), mar-
ital status (yes/no), and maternal age (restricted 
quadratic splines) (Durkin et al. 2008). Next, 
we evaluated whether county population size 
(in five categories as in NCHS data), birth year 
(as categories), and surveillance site (as catego-
ries) confounded our estimates.
We evaluated modification of the asso-
ciation between maternal smoking and ASD 
by a) child sex, because it has been found 
to modify other environmental–chemical– 
neurodevelopmental associations (Bellinger 
et al. 1990; Braun et al. 2011; Ris et al. 
2004); b) maternal race/ethnicity and c) edu-
cation; and variables that may capture dif-
ferences in ADDM surveillance activities or 
general temporal or spatial trends: d) birth 
year and e) county population size. Modifiers 
were  evaluated on the multiplicative scale by 
inspecting PRs stratified by the potential mod-
ifier and by performing likelihood ratio tests. 
The likelihood ratio tests compared a fully 
adjusted model to a model that additionally 
included cross-product terms between a poten-
tial modifier and maternal smoking. Factors 
for which the likelihood ratio test p‑value was 
< 0.10 were considered to modify the associa-
tion between maternal smoking and ASDs.
We repeated our multivariable models for 
several case subgroups in exploratory analy-
ses, assuming that different subgroups may 
exhibit differential susceptibility to tobacco 
smoke. Subgroups that corresponded to 
higher- and lower-functioning ASDs, such as 
subgroups based on co-occurring intellectual 
disabilities (ID), have been suggested as ASD 
endophenotypes that correspond to genetic 
liability (Szatmari et al. 2007). We used the 
following available variables from ADDM to 
define case subgroups: whether a prior com-
munity diagnosis was AD or ASD-NOS, the 
timing of first diagnosis (assuming that ear-
lier diagnosis in part served as a marker of 
more numerous or more severe symptoms), 
ADDM-determined subgroup (AD or ASD-
NOS), and the presence of co-occurring ID. 
Because of differences in the data available 
between sites and years, some analyses of ASD 
subgroups were limited to a data subset that 
contained the needed variables (Table 2).
Sensitivity analyses. Autism has consistently 
been found to be more prevalent in groups of 
higher social class in the United States, lead-
ing to concerns that autism may be under-
ascertained in children of lower social class. 
Such gradients are even found in ADDM 
data, despite its active surveillance methodol-
ogy that can recognize a case without a prior 
documented diagnosis (Durkin et al. 2010). 
To evaluate the impact of under-ascertainment 
on our results, we performed a sensitivity 
analysis correcting for such outcome misclas-
sification. Because of the strong association 
between maternal education and smoking in 
pregnancy (CDC 2010), ascertainment that 
varies by maternal education has the potential 
to affect results, even without an assumption of 
differential ASD ascertainment within smok-
ing strata. We used standard formulas to cor-
rect for outcome misclassification and varied 
the specificity assumptions as allowable with-
out creating negative cell counts (Rothman 
et al. 2008). We adjusted the number of cases 
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using different estimates of sensitivity in each 
stratum of maternal education, assuming the 
highest outcome sensitivity in the stratum with 
a college degree and comparatively less sensi-
tivity for all other educational strata based on 
the ASD prevalence observed in our data [see 
Supplemental Material, Table S1(http://ox.doi.
org/10.1289/ehp.1104556)]. This process 
assumed that only the surveillance ascertain-
ment of ASD, but not the true prevalence of 
the condition, varied by maternal education. 
We constrained our stratum- specific sensi tivity 
values so that the overall outcome sensi tivity 
corresponded to that found in an ADDM 
evaluation study: 0.60 (Avchen et al. 2010). 
Outcome sensitivity values for ASD by strata 
of maternal education were as follows: college 
degree: 0.80; some college: 0.72; high school 
degree: 0.53; and less than high school: 0.35 
(see Supplemental Material, Tables S1 and S2). 
We also performed outcome misclassification 
corrections separately for ADDM-determined 
AD and ASD-NOS (see Supplemental 
Material, Tables S1 and S3). After adjusting 
Table 1. Prevalence of ASDs and case subgroups by child and family characteristics, with characteristics of the source population








ASD with IDb 
(n = 584)
ASD without IDb 





Overall 5.2 4.4 1.3 2.2 2.9
Exposure
Smoking in pregnancy
Yes 4.4 3.7 1.5 1.7 2.7 83,883 13
No 5.3 4.5 1.2 2.3 2.9 550,106 87
Child Characteristics
Sex
Female 2.0 1.6 0.4 1.0 0.9 309,861 49 13
Male 8.2 7.0 2.1 3.4 4.8 324,128 51 13
Race/Ethnicity
Non-Hispanic white 5.8 5.3 1.6 1.7 3.6 385,493 61 16
Non-Hispanic black 4.5 3.6 0.9 3.1 1.9 186,113 29 10
Hispanic 3.4 2.7 0.7 1.6 1.7 45,541 7 4
Other 4.3 3.0 0.7 1.7 2.5 16,842 3 4
Family and county characteristics
Maternal education
< High school 3.1 2.4 0.8 2.0 1.4 117,300 19 26
High school degree 4.4 3.6 1.1 2.4 2.0 204,026 32 18
Some college 6.0 5.4 1.3 2.6 3.4 139,069 22 10
College degree 6.8 5.7 1.7 1.9 4.4 173,594 27 2
Maternal age (years)
10–19 2.6 1.9 0.8 1.7 1.2 81,090 13 16
20–24 4.0 3.3 0.9 1.9 1.8 147,507 23 17
25–29 5.3 4.1 1.3 2.2 2.9 173,152 27 12
30–34 6.4 5.6 1.5 2.5 3.6 154,651 24 11
35–39 7.6 6.6 1.7 3.0 4.9 66,354 10 11
40–53 8.4 7.1 1.7 2.2 7.0 11,235 2 10
Married
Yes 5.9 5.0 1.4 2.2 3.4 417,082 66 10
No 3.9 3.2 1.0 2.3 1.7 216,907 34 20
County population size
> 1,000,000 3.4 2.7 0.8 NI NI 52,236 8 8
500,000 – 1,000,000 5.5 4.3 1.6 2.3 2.2 216,687 34 11
250,000 – 500,000 5.9 5.1 1.2 2.2 3.6 160,247 25 12
100,000 – 250,000 5.0 5.0 1.2 2.4 2.5 131,894 21 16
< 100,000 4.5 4.4 1.3 1.9 2.9 72,925 12 24
Study design characteristics
Birth/surveillance year
1992/2000 4.4 3.3 1.5 1.8 2.0 65,899 10 15
1994/2002 4.5 NI NI 2.0 2.6 231,544 37 16
1996/2004 5.7 4.1 1.0 2.3 2.9 120,301 19 12
1998/2006 5.9 4.7 1.3 2.7 3.8 216,245 34 11
Site
AL 4.3 3.9 0.9 2.4 1.1 45,851 7 11
AR 5.0 NI NI 2.0 2.9 34,311 5 20
FL 2.7 2.0 0.7 NI NI 31,511 5 2
GA 5.3 4.4 1.0 2.1 2.9 159,493 25 7
MD 5.1 3.3 2.4 NI NI 70,698 12 13
MO 6.8 7.3 2.5 NI NI 84,359 13 16
NC 6.0 5.9 0.9 2.7 3.2 59,005 9 16
NJ 7.9 4.8 3.6 NI NI 14,291 2 7
PA 4.5 3.5 0.9 NI NI 20,725 3 16
WI 4.7 4.1 1.2 NI NI 70,912 11 17
WV 4.3 NI NI NI NI 42,833 7 27
Abbreviations: AD, autistic disorder; ASD, autism spectrum disorders; ASD-NOS, autistic spectrum disorder–not otherwise specified; ASD with ID, autism spectrum disorder with co-
occurring intellectual disability; ASD without ID, autism spectrum disorder without co-occurring intellectual disability; NI, not included. 
aAD and ASD-NOS subgroups refer to subgroups determined by ADDM clinicians. Subsets of ADDM data had available information on ADDM-determined AD and ASD-NOS. bAnother 
data subset had at least 80% complete data on co-occurring ID.
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numbers of cases and controls using an Excel 
spreadsheet, we calculated confidence intervals 
(CIs) using PROC Freq/CMH in SAS (SAS 
Institute Inc., Cary, NC) applied to the resul-
tant simulated data (Robins et al. 1986).
To evaluate a potential selection bias from 
including infants who died in the first year of 
life, we performed an analysis removing infant 
deaths in regions and years for which infor-
mation on infant death was available, using 
the Birth Cohort Linked Birth–Infant Death 
Data Files from NCHS (CDC 2009a). These 
files were available for birth years 1996 and 
1998 in counties with populations > 250,000.
We performed a subanalysis to evaluate the 
impact of residential mobility on our results, 
because the source population included chil-
dren who had moved out of the study area and 
could not be identified as ASD cases at age 8. 
This subanalysis was limited to children from 
North Carolina born in 1994 and 1996. We 
traced the residential histories of a random sam-
ple of this birth cohort to determine residency 
within the surveillance catchment area at age 8. 
Tracing was conducted by searching on mater-
nal and paternal names from the birth certifi-
cate using commercial databases of multiple 
residences over time provided by LexisNexis. 
We then compared PRs of smoking and ASD 
using a) a denominator of all included North 
Carolina children versus b) a denominator of 
children remaining within the North Carolina 
surveillance area.
Results
A total of 633,989 births met our inclusion 
criteria by residency and year of birth and 
had complete information on relevant covari-
ates. Of these, 3,315 met ADDM network 
surveillance criteria for an ASD at 8 years of 
age. Prevalence of ASDs was greater for non-
Hispanic whites than for other racial/ethnic 
groups and for married than for nonmarried 
mothers (Table 1). Prevalence of ASDs also 
increased with increasing maternal age. The 
ASD prevalence for children born to mothers 
with a college degree was more than twice 
that compared with mothers with less than a 
high school education. Patterns of higher ASD 
prevalence for non-Hispanic whites and with 
higher maternal education held for some case 
subgroups: ADDM-determined AD, ADDM-
determined ASD-NOS, and ASD without 
co-occurring ID. In contrast, the prevalence 
of ASD with co-occurring ID was almost two 
times as prevalent for non-Hispanic blacks 
compared with other racial/ethnic groups 
and did not exhibit a gradient across levels of 
maternal education (Table 1).
In our source population, 13% of all 
mothers smoked cigarettes during pregnancy 
(Table 1). The percent smoking in pregnancy 
was greater for mothers with lower education, 
younger age at her child’s birth, and not mar-
ried. Non-Hispanic white mothers were more 
likely to smoke during pregnancy compared 
with non-Hispanic black mothers. The asso-
ciation between maternal smoking and mater-
nal education was especially striking: Mothers 
with less than a high school education at the 
time of the child’s birth were 13 times as likely 
to smoke during pregnancy compared with 
those with a college degree.
Among children recognized by ADDM as 
having an ASD, fewer had a report of mater-
nal smoking in pregnancy (11%) compared 
with the source population (13%) (Table 2). 
The adjusted association between smoking 
and ASDs was inverse, with a lower preva-
lence of surveillance-ascertained ASD for 
women who reported smoking cigarettes in 
pregnancy compared with those who didn’t 
smoke (Figure 1A). Adjustment for mater-
nal age, education, and marital status brought 
estimates upward and closer to, but still below, 
the null, indicating a downward confounding 
bias. Maternal education was the strongest 
confounder. Additional adjustment for county 
population size, birth year, surveillance site, 
and a cross-product between birth year and 
surveillance site did not alter estimates (results 
not shown).
Figure 1. (A) Unadjusted and adjusted PRs (95% CI) of maternal smoking and ASD stratified by race/ethnicity. (B) Adjusted PRs (95% CI) of maternal smoking and ASD 









































































































































ADDM-ascertained ASD 3,315 11.2
Community provider diagnosesa Any AD 949 9.9
ASD and no AD 870 11.2
Timing of first community diagnosisa < 50 months 994 9.3
≥ 50 months 1,108 12.2
Source population with ADDM-determined subgroup
Births 297,493 10.7
ADDM-ascertained ASD 1,685 9.9
ADDM–designated subgroup AD 1,310 9.0
ASD-NOS 375 13.1
Source population with ID data
Births 261,786 11.1
ADDM-ascertained ASD 1,409 9.3
Co-occurring IDa Yes 584 8.4
No 754 10.3
Abbreviations: AD, autistic disorder; ADDM, Autism and Developmental Disabilities Monitoring Network; ASD, autism 
spectrum disorders; ASD-NOS, autistic spectrum disorder–not otherwise specified; ID, intellectual disability. 
aThese outcome subgroups do not add up to the total number of children with an ASD because some children were 
missing data needed to place them in a subgroup.
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Our criteria for modification of the asso-
ciation between maternal smoking and ASD 
were satisfied for race/ethnicity (likelihood 
ratio test p = 0.05): The estimated protective 
effect of maternal smoking on the prevalence 
of ASD appeared stronger for non-Hispanic 
blacks [PR = 0.72 (95% CI: 0.56, 0.93)] than 
for non-Hispanic whites [PR = 0.90 (95% 
CI: 0.79, 1.03)] (Figure 1A). Other potential 
modifiers (child’s sex, maternal education, 
birth-year, and county population size) did 
not meet modification criteria. For example, 
the likelihood ratio test of modification by 
child’s sex yielded p = 0.49; adjusted PRs and 
95% CIs of maternal smoking in pregnancy 
and ASD were, for girls: 0.83 (0.64, 1.08) 
and for boys: 0.92 (0.81, 1.05).
We considered case subgroups defined 
by whether children with an ASD had other 
recorded characteristics or prior diagnoses 
that may indicate higher-functioning (such as 
ASD-NOS or ASD without co-occurring ID) 
or lower-functioning characteristics (such as 
AD or ASD with ID). Similarly to the inverse 
crude association between maternal smok-
ing with ASDs overall, the proportion with 
maternal smoking in pregnancy was generally 
lower for these case subgroups than for the 
corresponding source populations (Table 2). 
For example, 9.0% of ADDM-determined 
AD reported maternal smoking compared 
with 10.7% in the corresponding source 
population. One notable exception was that 
children with ADDM-determined ASD-NOS 
(13.1%) had mothers who smoked, compared 
with 10.7% in the source population.
We examined adjusted associations between 
maternal smoking in pregnancy with each 
case subgroup. A consistent pattern emerged 
whereby lower-functioning subgroups had 
inverse associations with maternal smoking, 
whereas higher-functioning subgroups had null 
or positive associations (Figure 1B). Lower-
functioning subgroups with below-null associa-
tions were community-diagnosed AD, earlier 
community diagnosis, ADDM-determined 
AD, and ASD with co-occurring ID. The 
higher-functioning subgroups with near-null 
associations with maternal smoking included 
community diagnosis of ASD without AD, a 
later community diagnosis, and ASD without 
co-occurring ID. The higher-functioning sub-
group with a positive association was ADDM-
determined ASD-NOS. Although the pattern 
of inverse point estimates for lower-functioning 
ASD subtypes versus positive point estimates 
for higher-functioning ASD subtypes held 
across all available subgrouping variables, it 
should be noted that all 95% CIs included the 
null and exhibited some degree of overlap with 
the complementary case subgroup.
Sensitivity analysis results. Our sensitivity 
analysis of differential outcome misclassifica-
tion by level of maternal education yielded 
corrected PRs that were higher than the 
naive unadjusted estimates [Figure 1C; also 
see Supplemental Material, Tables S2 and S3 
(http://ox.doi.org/10.1289/ehp.1104556)]. 
This upward correction held for all ASDs and 
the case subgroups AD and ASD-NOS as 
determined by ADDM clinicians, resulting in 
positive associations with maternal smoking 
across the board. The strongest association 
with maternal smoking was found for the 
higher-functioning case subgroup, ASD-NOS, 
with a corrected unadjusted association of 
1.64 (95% CI: 1.34, 2.01).
Outcome misclassification–corrected 
results were affected by the assumed level of 
specificity (i.e., the estimated proportion of 
negative diagnoses that are correct). For exam-
ple, the corrected result for all ASDs assuming 
a specificity of 0.998 was 0.94 (95% CI: 0.85, 
1.04) compared with that assuming a speci-
ficity of 1.00: 1.04 (95% CI: 0.96, 1.12). 
We could not assume a specificity lower than 
0.998 because such assumptions resulted in 
negative cell counts.
The subanalysis to assess the impact of 
removing infant deaths from the denomi-
nator used a subsample of 273,454 births. 
The adjusted PR limited to these areas with 
available data on infant mortality and retain-
ing infant deaths was almost identical to the 
adjusted estimate excluding infant deaths 
(data not shown).
Our sensitivity analysis of a potential bias 
due to residential mobility, which was limited 
to North Carolina data, suggested no impact. 
The PR using the included North Carolina 
birth cohort as a denominator was almost 
identical to the PR using the subset of those 
children who resided within the surveillance 
area at age 8 years (data not shown). This 
result suggested that this bias due to missing 
cases is minimal in this region where approxi-
mately 10% migrated out of the surveillance 
area between birth and age 8 years.
Discussion
Using autism surveillance and birth certificate 
data, we estimated the association between 
maternal smoking in pregnancy with ASDs 
identified among children 8 years of age. The 
primary analyses indicated a slightly inverse 
association with all ASDs and a suggestion 
that associations may differ by case subgroups. 
Sensitivity analyses that assumed ASD under-
ascertainment varied by level of maternal 
education raised the possibility that observed 
protective associations between maternal 
smoking in pregnancy and ASDs were biased 
downward. If true, associations with maternal 
smoking may generally be null, but may differ 
by ASD subgroup.
Associations between maternal smok-
ing and higher-functioning ASD subgroups 
may be positive, in contrast to those with 
lower-functioning ASD subgroups, which 
appeared null. Such findings are consistent 
with results from a large study using Swedish 
record linkages that also found higher, above-
null associations with ASD without co-oc-
curring ID, a higher functioning subgroup 
[PR observed to be approximately 1.13 
(95% CI: 0.95, 1.25)] and inverse associa-
tions for ASD with co-occurring ID, a low-
er-functioning subgroup [PR approximately 
0.91 (95% CI: 0.78, 1.06)] (Lee et al. 2011). 
Other findings that suggest more suscepti-
bility for children with higher-functioning 
ASDs include a reported association between 
maternal smoking and scores on the Autism 
Spectrum Screening Questionnaire, an instru-
ment designed to screen for symptoms of 
Asperger’s disorder and higher-functioning 
autism, among adolescents (Ehlers et al. 1999; 
Indredavik et al. 2007). Last, a prior U.S. 
study found a stronger positive association 
between maternal smoking in pregnancy for 
children with the broader classification of per-
vasive developmental disorder not otherwise 
specified compared with AD (Juul-Dam et al. 
2001). Taken together, these findings raise the 
possibility that a higher-functioning subgroup 
of ASDs may be etiologically distinct and 
influenced by maternal smoking in pregnancy.
Our analyses suggesting that higher-
functioning ASD subgroups may be caused 
in part by maternal smoking in pregnancy 
had several limitations and warrant cautious 
interpretation. The ASD subgroup variables 
were imperfect, relying on the child’s access 
to evaluation services and the documentation 
by a myriad of community providers, rather 
than direct clinical observation. An alternative 
explanation of the findings of a positive asso-
ciation for ADDM-determined ASD-NOS is 
that it is spurious, given the many subgroups 
examined. In addition, it is the smallest sub-
group and may have incurred a larger degree 
of bias away from the null than the more 
common subgroups (Nemes et al. 2009). This 
higher-functioning subgroup may be more 
heterogeneous and so may contain children 
with other developmental delays, such as co-
occurring attention deficit/hyperactivity dis-
order, known to be associated with nicotine 
exposure (Braun et al. 2006; Goldstein and 
Schwebach 2004; Simonoff et al. 2008).
Our sensitivity analysis of the impact of 
under-ascertainment of ASD in children with 
mothers of lower education indicated the 
possibility of a downward bias, so that asso-
ciations were elevated after correction. If, as we 
assumed, ASDs are under-ascertained in groups 
with lower maternal education in ADDM data, 
a bias may occur because of the strong associa-
tion between maternal education and smoking 
patterns. Because the same variable—maternal 
education—was used to apply weighted out-
come misclassification corrections, and serves 
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as the most important confounder, simultane-
ous consideration of confounding and out-
come misclassification was not possible, and 
is a limitation of this approach. Such results 
must be interpreted with caution; they are 
contingent on the correctness of assumptions. 
Furthermore, the stated CIs do not account for 
all layers of uncertainty implicit in a sensitivity 
analysis, and so are too narrow to reflect the 
95% coverage.
Future studies must account for the poten-
tial of under-ascertainment bias for studies 
of ASDs and exposures that vary with social 
class. Almost all environmental risk factors 
exhibit such gradients. We recommend that a 
cohort be comprehensively evaluated for ASDs 
or that assessment of ASD symptoms occur 
independently of access to services. The poten-
tial for this type of bias in studies of environ-
mental contaminants is not limited to ASDs, 
but may occur for other health outcomes in 
which diagnosis is complicated and sensitive 
to demographic and societal influences.
Differences in ascertainment may help 
to explain discrepancies between overall null 
results found in these U.S. data with elevated 
associations found in some European studies 
(Hultman et al. 2002; Larsson et al. 2005; 
Larsson et al. 2009). The European studies 
took place in a context of universal access to 
diagnostic services, so that underascertain-
ment may be infrequent. The social context of 
smoking also differs in some areas of Europe: 
Smoking is not as strongly associated with 
lower maternal education as it is in the United 
States, raising the possibility that a different 
direction of confounding bias contributed to 
different results between studies. Indeed, the 
direction of confounding by social factors in a 
similar large study in Sweden was upward, so 
that when accounted for, elevated associations 
were attenuated to the null (Lee et al. 2011). 
This is in contrast to confounding in these 
U.S. data, in which adjustment for social fac-
tors resulted in higher estimates.
Several explanations are consistent with 
the modification of the smoking-ASD asso-
ciation by race/ethnicity observed in these 
data. Residual confounding may play out dif-
ferently by racial/ethnic group. Race may be 
serving as a marker of access to developmental 
evaluation services, beyond that captured by 
maternal education (Mandell et al. 2009). 
Observed modification may reflect differences 
in case phenotype; for example, non-Hispanic 
blacks were more likely to have co-occurring 
ID in our data compared with other racial/
ethnic groups. Consequently, if associations 
between smoking and ASD vary by the pres-
ence of co-occurring ID, observed associations 
for non-Hispanic blacks will reflect a differ-
ent weighting of these subgroups. Tobacco 
exposure–related factors may also be at play in 
the observed modification by race/ethnicity: 
Non-Hispanic black mothers smoked fewer 
cigarettes in these data than did non-Hispanic 
white mothers, and consistent evidence sup-
ports that the metabolism of tobacco smoke 
constituents differs by race/ethnicity (Perez-
Stable et al. 1998).
Strengths of our design included a popu-
lation base, large sample size, and information 
on autism characteristics and co-occurring 
conditions. These characteristics allowed us 
to estimate effects separately by racial/ ethnic 
group and case subgroup with reasonable 
precision. Case ascertainment was standard-
ized based on DSM-IV-TR criteria and sub-
ject to rigorous quality control procedures 
(Van Naarden Braun et al. 2007). Additional 
strengths of our design included the multiple 
sensitivity analyses to explore data limitations, 
suggesting that the impacts of infant deaths 
and outward migration were negligible.
Birth certificate reports of maternal smok-
ing in pregnancy are considered to be of reason-
able quality, with a 0.8 concordance with the 
medical record (Dietz et al. 2011). Advantages 
of this measure include that it occurs before the 
development of ASD symptoms, and so is not 
subject to recall bias that differs by outcome 
status. Limitations of our exposure measure 
include that it does not reflect secondhand 
smoke exposure, does not include postnatal 
exposure, and does not capture differences in 
cigarette composition, inhalation, or metabo-
lism. Some studies have suggested that birth 
certificate underreporting of smoking may 
be greater with higher maternal education 
(Vinikoor et al. 2010). Our preliminary evalu-
ations of the impact of differential exposure 
misclassification by maternal education sug-
gested a negligible impact on findings.
Conclusions
After correcting for expected bias due to dif-
ferential under-ascertainment by maternal 
education, no association between maternal 
smoking in pregnancy and ASDs, generally, 
was apparent. The positive association with 
ASD-NOS, albeit observed in a small and het-
erogeneous subgroup, suggests that the higher-
functioning disorders on the autism spectrum 
may be influenced by maternal smoking in 
pregnancy, and deserve further attention.
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